Bioprocess

Following identification and development of therapeutic antibodies and recombinant proteins, subsequent process and product stability monitoring prior to final formulation into a pharmaceutically active product is required. The main objective for successful downstream protein processing is a product of high purity, activity and yield. The optimized process must deliver consistent batch-to-batch reproducibility and minimize endotoxin and host protein contamination economically.

Find the Products You Need

Product Range Highlights

Enabling Solutions for Bioprocess Optimization.

PEGylated Protein ELISA for the sensitive detection of a diverse set of PEGs in biological samples.

Facilitate screening of refolding parameters for a specific protein with ProteoStat® Protein Refolding and Aggregate Sensing Assay.

Looking for a new way to measure protein aggregation in your product ?
Try ProteoStat® Protein Aggregation Assay.

ProteoStat® Protein Aggregation Standards are the only commercially available protein aggregation standards assay with stabilized, high-quality reference IgG in known concentrations.

Rapidly screen conditions to help stabilize therapeutic proteins and prevent their aggregation with ProteoStat® Thermal Shift Stability Assay.

Detect Protein A residuals with the Protein A ELISA Kit for Contamination Analysis.

Custom Immunoassay Development Service. Put our immunoassay experts to work for you.

Screen-Well™ Compound Libraries – focused collections of compounds for drug discovery.